Phytosomes: A promising nanocarrier system for enhanced bioavailability and therapeutic efficacy of herbal products

• Phytosomes enhance the bioavailability and efficacy of phytoconstituents. • Phytosomes overcome solubility and absorption issues in herbal drugs. • Phytosomes show higher stability and drug loading than liposomes. • Key phytosomal compounds are used to treat cancer, osteoarthritis, and metabolic syndrome. Herbal products have revealed a variety of therapeutic potential in numerous health conditions. However, limitations regarding their solubility, absorption, bioavailability, and stability have hindered clinical translations. Among various strategies to combat these challenges, using phytosomes as a nanocarrier system has presented a promising approach to enhance the bioavailability and effectiveness of phytoconstituents. This study comprehensively reviews the development, preparation, and advantages of phytosomes as a novel nanodelivery system, focusing on overcoming the pharmacokinetic limitations of phytoconstituents. A scientific literature search was conducted using databases including PubMed, Web of Science, Scopus, and Google Scholar. Keywords such as “phytosome,” “herbasome,” “herbal drug delivery,” and “phospholipid complex” were employed to identify appropriate scientific articles. Phytosomal delivery systems have demonstrated significant improvements in bioavailability, therapeutic outcomes, stability, and targeted distribution of herbal products. Compared to other delivery systems like liposomes, phytosomes exhibit superior pharmacokinetic profiles and distribution efficiency. They show promise in enhancing bioavailability and enabling diverse routes of administration, including oral, topical, and intranasal. They also have numerous therapeutic applications in inflammatory diseases, neurological disorders, cancers, metabolic syndrome, and liver diseases. Phytosomal delivery systems effectively address the pharmacokinetic challenges of herbal products, offering improved bioavailability, stability, and therapeutic outcomes.

Authors

Institutions

Publication Details

Journal
Phytomedicine Plus
Published
2025-03-07
DOI
https://doi.org/10.1016/j.phyplu.2025.100779
Citations
22
Primary Topic
Silymarin and Mushroom Poisoning
Type
article
Field-Weighted Citation Impact
33.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phytosomes: A promising nanocarrier system for enhanced bioavailability and therapeutic efficacy of herbal products

Kimia Shahbazi, Mahdyeh Sashourpour, Faraz Mojab, Mohammad Sedigh Dakkali et al.
22 citations
Phytomedicine Plus
Silymarin and Mushroom Poisoning
33.40
article

Phytosomes: A promising nanocarrier system for enhanced bioavailability and therapeutic efficacy of herbal products

Kimia Shahbazi, Mahdyeh Sashourpour, Faraz Mojab, Mohammad Sedigh Dakkali, M Akbari, Seyedali Hashemi, Marjan Talebi, Rouzbeh Almasi Ghale, Saeed Aminzadeh
article en
22 citations

Abstract

• Phytosomes enhance the bioavailability and efficacy of phytoconstituents. • Phytosomes overcome solubility and absorption issues in herbal drugs. • Phytosomes show higher stability and drug loading than liposomes. • Key phytosomal compounds are used to treat cancer, osteoarthritis, and metabolic syndrome. Herbal products have revealed a variety of therapeutic potential in numerous health conditions. However, limitations regarding their solubility, absorption, bioavailability, and stability have hindered clinical translations. Among various strategies to combat these challenges, using phytosomes as a nanocarrier system has presented a promising approach to enhance the bioavailability and effectiveness of phytoconstituents. This study comprehensively reviews the development, preparation, and advantages of phytosomes as a novel nanodelivery system, focusing on overcoming the pharmacokinetic limitations of phytoconstituents. A scientific literature search was conducted using databases including PubMed, Web of Science, Scopus, and Google Scholar. Keywords such as “phytosome,” “herbasome,” “herbal drug delivery,” and “phospholipid complex” were employed to identify appropriate scientific articles. Phytosomal delivery systems have demonstrated significant improvements in bioavailability, therapeutic outcomes, stability, and targeted distribution of herbal products. Compared to other delivery systems like liposomes, phytosomes exhibit superior pharmacokinetic profiles and distribution efficiency. They show promise in enhancing bioavailability and enabling diverse routes of administration, including oral, topical, and intranasal. They also have numerous therapeutic applications in inflammatory diseases, neurological disorders, cancers, metabolic syndrome, and liver diseases. Phytosomal delivery systems effectively address the pharmacokinetic challenges of herbal products, offering improved bioavailability, stability, and therapeutic outcomes.

Phytomedicine PlusVol. 5(2)
Shahrekord University (IR), Iranian Research Organization for Science and Technology (IR), Zahedan University of Medical Sciences (IR), National Institute of Genetic Engineering and Biotechnology (IR), Shahid Beheshti University of Medical Sciences (IR)
Zero hunger
Openalex Percentile: Top 0%
Silymarin and Mushroom Poisoning
33.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.